Skip to main content
Martha Wadleigh, MD, Oncology, Boston, MA

MarthaWadleighMD

Oncology Boston, MA

Hematologic Oncology

Assistant Professor of Medicine, Dana-Farber Cancer Institute

Dr. Wadleigh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wadleigh's full profile

Already have an account?

  • Office

    44 Binney St
    # 1B25
    Boston, MA 02115
    Phone+1 617-632-6685
    Fax+1 617-582-8202

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2001 - 2004
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1998 - 2001
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1998

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2004 - 2025
  • NH State Medical License
    NH State Medical License 2024 - 2024
  • NC State Medical License
    NC State Medical License 1998 - 2001
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical, Clinical, and Correlative Studies
    Martha Wadleigh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for Untreated BCR-ABL1-Positive ALL in Older Adults
    Martha Wadleigh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • A Phase 1 Dose-Escalation Study of Adding Venetoclax to a Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic Hematopoietic Cell Transplantation for Patie...
    Martha Wadleigh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Quality of Life and Psychological Distress in Patients with Acute Myeloid Leukemia (AML) 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Victor Paul Berardi, 69
    Victor Paul Berardi, 69May 6th, 2020
  • 6 Signs of Leukemia Every Woman Needs to Know
    6 Signs of Leukemia Every Woman Needs to KnowMarch 1st, 2017

Professional Memberships